CompletedNot Applicable

Comparison of First and Second Capillary Blood Drops for Blood Glucose Measurement

Turkey (Türkiye)64 participantsStarted 2025-02-01

Plain-language summary

This study aimed to evaluate the effects of different capillary blood sampling techniques on blood glucose measurement results in people with diabetes. Blood glucose measurements obtained from the first and second capillary blood drops after antiseptic application were compared. In addition, measurements obtained with and without finger squeezing were evaluated. The findings may contribute to improving standardization in capillary blood glucose monitoring procedures and reducing unnecessary repeated finger punctures in clinical practice.

Who can participate

Age range

18 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 18 years or older * Diagnosed with diabetes mellitus * Provided written and verbal informed consent to participate in the study * Eligible for blood glucose measurement after at least 6 hours of fasting * No condition preventing capillary blood sampling from the fingertip * Physically and mentally able to undergo the measurement procedures specified in the study Exclusion Criteria: * Presence of a physical disability or deformity affecting fingertip blood glucose measurement * Presence of coagulation disorders (e.g., hemophilia) or severe medical conditions affecting blood sampling * Use of steroids within the previous 24 hours that could affect blood glucose levels * Presence of physical or mental conditions limiting compliance with study procedures * Inability or unwillingness to provide informed consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Difference between blood glucose measurements obtained with and without finger squeezing

Timeframe: Day 1

Difference between blood glucose values obtained from the first and second capillary blood drops following antiseptic application

Timeframe: Day 1

Trial details

NCT IDNCT07624266

SponsorOrdu University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-07-30

View on ClinicalTrials.gov More Diabetes Mellitus trials